Pharmacophore Modeling and Docking Studies on Some Nonpeptide-Based Caspase-3 Inhibitors
Figure 4
Pictorial representation of cubes for the most active (compound 58) and the least active (compound 6b) compounds where blue and red cubes show favorable and unfavorable regions for activity.